Annual Long Term Debt
$22.18 M
-$3.11 M-12.31%
31 December 2023
Summary:
Black Diamond Therapeutics annual long term debt is currently $22.18 million, with the most recent change of -$3.11 million (-12.31%) on 31 December 2023. During the last 3 years, it has risen by +$14.49 million (+188.34%). BDTX annual long term debt is now -21.16% below its all-time high of $28.14 million, reached on 31 December 2021.BDTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$19.67 M
-$856.00 K-4.17%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly long term debt is currently $19.67 million, with the most recent change of -$856.00 thousand (-4.17%) on 30 September 2024. Over the past year, it has dropped by -$3.33 million (-14.47%). BDTX quarterly long term debt is now -31.74% below its all-time high of $28.82 million, reached on 30 September 2021.BDTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.3% | -14.5% |
| 3 y3 years | +188.3% | -31.7% |
| 5 y5 years | - | - |
BDTX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.2% | +188.3% | -31.7% | at low |
| 5 y | 5 years | -21.2% | -31.7% | ||
| alltime | all time | -21.2% | -31.7% |
Black Diamond Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.67 M(-4.2%) |
| June 2024 | - | $20.53 M(-3.9%) |
| Mar 2024 | - | $21.36 M(-3.7%) |
| Dec 2023 | $22.18 M(-12.3%) | $22.18 M(-3.5%) |
| Sept 2023 | - | $23.00 M(-3.3%) |
| June 2023 | - | $23.78 M(-3.1%) |
| Mar 2023 | - | $24.55 M(-3.0%) |
| Dec 2022 | $25.30 M | $25.30 M(-2.9%) |
| Sept 2022 | - | $26.04 M(-2.7%) |
| June 2022 | - | $26.76 M(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $27.45 M(-2.4%) |
| Dec 2021 | $28.14 M(+265.7%) | $28.14 M(-2.3%) |
| Sept 2021 | - | $28.82 M(+115.4%) |
| June 2021 | - | $13.38 M(-3.1%) |
| Mar 2021 | - | $13.80 M(+79.4%) |
| Dec 2020 | $7.69 M(>+9900.0%) | $7.69 M(-0.7%) |
| Sept 2020 | - | $7.75 M(+4066.1%) |
| June 2020 | - | $186.00 K(-22.2%) |
| Mar 2020 | - | $239.00 K(>+9900.0%) |
| Dec 2019 | $0.00 | $0.00 |
FAQ
- What is Black Diamond Therapeutics annual long term debt?
- What is the all time high annual long term debt for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual long term debt year-on-year change?
- What is Black Diamond Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly long term debt year-on-year change?
What is Black Diamond Therapeutics annual long term debt?
The current annual long term debt of BDTX is $22.18 M
What is the all time high annual long term debt for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual long term debt is $28.14 M
What is Black Diamond Therapeutics annual long term debt year-on-year change?
Over the past year, BDTX annual long term debt has changed by -$3.11 M (-12.31%)
What is Black Diamond Therapeutics quarterly long term debt?
The current quarterly long term debt of BDTX is $19.67 M
What is the all time high quarterly long term debt for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly long term debt is $28.82 M
What is Black Diamond Therapeutics quarterly long term debt year-on-year change?
Over the past year, BDTX quarterly long term debt has changed by -$3.33 M (-14.47%)